Sonnet Biotherapeutics Holdings Inc Capital Reinvestment Ratio

Latest as of September 2018: 1.54x

Sonnet Biotherapeutics Holdings Inc capital reinvestment ratio. Sonnet Biotherapeutics Holdings Inc (SONN) has a Capital Reinvestment Ratio of 1.54x as of September 2018, meaning it reinvests 2% of its operating cash flow ($670.16K) in capital expenditures ($1.03 Million). Check cash flow reinvestment rate of Sonnet Biotherapeutics Holdings Inc to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

1.54x

Capex / Operating Cash Flow

Operating Cash Flow

$670.16K

USD

Capital Expenditures

$1.03 Million

USD

Data as of

Sep 2018

Most recent filing

Sonnet Biotherapeutics Holdings Inc Capital Reinvestment Ratio by Year (None–None)

Sonnet Biotherapeutics Holdings Inc capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see cash efficiency ratio of Sonnet Biotherapeutics Holdings Inc.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow